Protective role of IFN-γ in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production

Journal of Leukocyte Biology

Volumn 81, Issue 4, 2007, Pages 1044-1053

  Kelchtermans, Hilde ^a   Struyf, Sofie ^a   De Klerck, Bert ^a   Mitera, Tania ^a   Alen, Marijke ^a   Geboes, Lies ^a   Van Balen, Maarten ^a   Dillen, Chris ^a   Put, Willy ^a   Gysemans, Conny ^b   Billiau, Alfons ^a   Van Damme, Jo ^a   Matthys, Patrick ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Chemokines; Mice; Neutrophils

Indexed keywords

ALPHA CHEMOKINE; COLLAGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; NEUTRALIZING ANTIBODY; PROTEIN GRANULOCYTE CHEMOTACTIC PROTEIN 2; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELLULAR IMMUNITY; DISEASE SEVERITY; DOWN REGULATION; EMBRYO; FIBROBLAST; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; MYCOBACTERIUM; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SPLEEN; SYNOVIAL FLUID;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; CHEMOKINES, CXC; CHEMOTAXIS; COLLAGEN TYPE II; DOWN-REGULATION; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM; SYNOVIAL FLUID;

CORYNEBACTERINEAE; MUS;

EID: 33947647376     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0806486     Document Type: Article

References (66)

1. Matthys, P., Vermeire, K., Billiau, A. (2001) Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects of IFN-γ in autoimmune disease models. Trends Immunol. 22, 367-371.
2. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A., Mosedale, B. (1980) Immunization against heterologous type II collagen induces arthritis in mice. Nature 283, 666-668.
3. Vermeire, K., Heremans, H., Vandeputte, M., Huang, S., Billiau, A., Matthys, P. (1997) Accelerated collagen-induced arthritis in IFN-γ receptor-deficient mice. J. Immunol. 158, 5507-5513.
4. Manoury-Schwartz, B., Chiocchia, G., Bessis, N., Abehsira-Amar, O., Batteux, F., Muller, S., Huang, S., Boissier, M. C., Fournier, C. (1997) High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158, 5501-5506.
5. Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., De Wolf-Peeters, C., Billiau, A. (1999) Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J. Immunol. 163, 3503-3510.
6. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., Fathman, C. G. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156, 5-7.
7. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., Ramshaw, I. A. (1996) IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157, 3223-3227.
8. Jones, L. S., Rizzo, L. V., Agarwal, R. K., Tarrant, T. K., Chan, C. C., Wiggert, B., Caspi, R. R. (1997) IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158, 5997-6005.
9. Peichl, P., Pursch, E., Broll, H., Lindley, I. J. (1999) Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation. Rheumatol. Int. 18, 141-145.
10. Kraan, M. C., Patel, D. D., Haringman, J. J., Smith, M. D., Weedon, H., Ahern, M. J., Breedveld, F. C., Tak, P. P. (2001) The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res. 3, 65-71.
11. Van den Steen, P. E., Proost, P., Grillet, B., Brand, D. D., Kang, A. H., Van Damme, J., Opdenakker, G. (2002) Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 16, 379-389.
12. Rampart, M., Herman, A. G., Grillet, B., Opdenakker, G., Van Damme, J. (1992) Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease. Lab. Invest. 66, 512-518.
13. Lukacs, N. W., Strieter, R. M., Standiford, T. J., Kunkel, S. L. (1996) Characterization of chemokine function in animal models of diseases. Methods 10, 158-165.
14. Koch, A. E., Kunkel, S. L., Burrows, J. C., Evanoff, H. L., Haines, G. K., Pope, R. M., Strieter, R. M. (1991) Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J. Immunol. 147, 2187-2195.
15. Endo, H., Akahoshi, T., Nishimura, A., Tonegawa, M., Takagishi, K., Kashiwazaki, S., Matsushima, K., Kondo, H. (1994) Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clin. Exp. Immunol. 96, 31-35.
16. Wuyts, A., Haelens, A., Proost, P., Lenaerts, J. P., Conings, R., Opdenakker, G., Van Damme, J. (1996) Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J. Immunol. 157, 1736-1743.
17. Wuyts, A., D'Haese, A., Cremers, V., Menten, P., Lenaerts, J. P., De Loof, A., Heremans, H., Proost, P., Van Damme, J. (1999) NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. J. Immunol. 163, 6155-6163.
18. Smith, J. B., Herschman, H. R. (1995) Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine. J. Biol. Chem. 270, 16756-16765.
19. Dijkmans, R., Volckaert, G., Van Damme, J., De Ley, M., Billiau, A., De Somer, P. (1985) Molecular cloning of murine interferon γ (MuIFN-γ) cDNA and its expression in heterologous mammalian cells. J. Interferon Res. 5, 511-520.
20. Heremans, H., Van Damme, J., Dillen, C., Dijkmans, R., Billiau, A. (1990) Interferon γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J. Exp. Med. 171, 1853-1869.
21. Van Coillie, E., Van Aelst, I., Wuyts, A., Vercauteren, R., Devos, R., Wolf-Peeters, C., Van Damme, J., Opdenakker, G. (2001) Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle. Am. J. Pathol. 159, 1405-1414.
22. Tagawa, Y., Sekikawa, K., Iwakura, Y. (1997) Suppression of concanavalin A-induced hepatitis in IFN-γ(-/-) mice, but not in TNF-α(-/-) mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159, 1418-1428.
23. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M., Aguet, M. (1993) Immune response in mice that lack the interferon-γ receptor. Science 259, 1742-1745.
24. De Klerck, B., Carpentier, I., Lories, R. J., Habraken, Y., Piette, J., Carmeliet, G., Beyaert, R., Billiau, A., Matthys, P. (2004) Enhanced osteoclast development in collagen-induced arthritis in interferon-γ receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis. Arthritis Res. Ther. 6, R220-R231.
25. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
26. Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T. M., Amakawa, R., Kishihara, K., Wakeham, A. (1993) Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83-97.
27. Livak, K. J., Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Δ Δ C(T)) method. Methods 25, 402-408.
28. Wuyts, A., Struyf, S., Gijsbers, K., Schutyser, E., Put, W., Conings, R., Lenaerts, J. P., Geboes, K., Opdenakker, G., Menten, P., Proost, P., Van Damme, J. (2003) The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1β and is down-regulated by interferon-γ: comparison with interleukin-8/CXCL8. Lab. Invest. 83, 23-34.
29. Ramana, C. V., Gil, M. P., Schreiber, R. D., Stark, G. R. (2002) Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23, 96-101.
30. Ivashkiv, L. B., Hu, X. (2003) The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum. 48, 2092-2096.
31. Chu, C. Q., Song, Z., Mayton, L., Wu, B., Wooley, P. H. (2003) IFNγ deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vβ6 and Vβ8 in arthritic joints. Ann. Rheum. Dis. 62, 983-990.
32. Guedez, Y. B., Whittington, K. B., Clayton, J. L., Joosten, L. A., van de Loo, F. A., van den Berg, W. B., Rosloniec, E. F. (2001) Genetic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44, 2413-2424.
33. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., Carton, H. (1988) Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140, 1506-1510.
34. Duong, T. T., Finkelman, F. D., Singh, B., Strejan, G. H. (1994) Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53, 101-107.
35. Lublin, F. D., Knobler, R. L., Kalman, B., Goldhaber, M., Marini, J., Perrault, M., D'Imperio, C., Joseph, J., Alkan, S. S., Korngold, R. (1993) Monoclonal anti-γ interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16, 267-274.
36. Krakowski, M., Owens, T. (1996) Interferon-γ confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26, 1641-1646.
37. Caspi, R. R., Chan, C. C., Grubbs, B. G., Silver, P. B., Wiggert, B., Parsa, C. F., Bahmanyar, S., Billiau, A., Heremans, H. (1994) Endogenous systemic IFN-γ has a protective role against ocular autoimmunity in mice. J. Immunol. 152, 890-899.
38. Chu, C. Q., Wittmer, S., Dalton, D. K. (2000) Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 123-128.
39. Kelchtermans, H., De Klerck, B., Mitera, T., Van Balen, M., Bullens, D., Billiau, A., Leclercq, G., Matthys, P. (2005) Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ. Arthritis Res. Ther. 7, R402-R415.
40. Wood, K. J., Sawitzki, B. (2006) Interferon γ: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27, 183-187.
41. Biermann, H., Pietz, B., Dreier, R., Schmid, K. W., Sorg, C., Sunderkotter, C. (1999) Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J. Leukoc. Biol. 65, 217-231.
42. Kitsis, E., Weissmann, G. (1991) The role of the neutrophil in rheumatoid arthritis. Clin. Orthop. Relat. Res. Apr., 63-72.
43. De Clerck, L. S., De Gendt, C. M., Bridts, C. H., Van Osselaer, N., Stevens, W. J. (1995) Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity. Res. Immunol. 146, 81-87.
44. Pillinger, M. H., Abramson, S. B. (1995) The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21, 691-714.
45. Kunkel, S. L., Lukacs, N., Kasama, T., Strieter, R. M. (1996) The role of chemokines in inflammatory joint disease. J. Leukoc. Biol. 59, 6-12.
46. Van Damme, J., Wuyts, A., Froyen, G., Van Coillie, E., Struyf, S., Billiau, A., Proost, P., Wang, J. M., Opdenakker, G. (1997) Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J. Leukoc. Biol. 62, 563-569.
47. Tran, E. H., Prince, E. N., Owens, T. (2000) IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164, 2759-2768.
48. Pierer, M., Rethage, J., Seibl, R., Lauener, R., Brentano, F., Wagner, U., Hantzschel, H., Michel, B. A., Gay, R. E., Gay, S., Kyburz, D. (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172, 1256-1265.
49. Lin, Y., Zhang, M., Barnes, P. F. (1998) Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66, 1121-1126.
50. Proost, P., Vynckier, A. K., Mahieu, F., Put, W., Grillet, B., Struyf, S., Wuyts, A., Opdenakker, G., Van Damme, J. (2003) Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur. J. Immunol. 33, 3146-3153.
51. Proost, P., Verpoest, S., Van de Borne, K., Schutyser, E., Struyf, S., Put, W., Ronsse, I., Grillet, B., Opdenakker, G., Van Damme, J. (2004) Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-γ in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J. Leukoc. Biol. 75, 777-784.
52. Hu, X., Ho, H. H., Lou, O., Hidaka, C., Ivashkiv, L. B. (2005) Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J. Immunol. 175, 131-138.
53. Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., Kunkel, S. L. (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95, 2868-2876.
54. Tumpey, T. M., Fenton, R., Molesworth-Kenyon, S., Oakes, J. E., Lausch, R. N. (2002) Role for macrophage inflammatory protein 2 (MIP-2), MIP-1, and interleukin-1 in the delayed-type hypersensitivity response to viral antigen. J. Virol. 76, 8050-8057.
55. Kudo, C., Yamashita, T., Terashita, M., Sendo, F. (1993) Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. II. Inhibition by RP-3 treatment of mononuclear leukocyte recruitment in delayed-type hypersensitivity to sheep red blood cells in rats. J. Immunol. 150, 3739-3746.
56. Kudo, C., Yamashita, T., Araki, A., Terashita, M., Watanabe, T., Atsumi, M., Tamura, M., Sendo, F. (1993) Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats. J. Immunol. 150, 3728-3738.
57. Larsen, C. G., Thomsen, M. K., Gesser, B., Thomsen, P. D., Deleuran, B. W., Nowak, J., Skodt, V., Thomsen, H. K., Deleuran, M., Thestrup-Pedersen, K. (1995) The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J. Immunol. 155, 2151-2157.
58. Maletto, B. A., Ropolo, A. S., Alignani, D. O., Liscovsky, M. V., Ranocchia, R. P., Moron, V. G., Pistoresi-Palencia, M. C. (2006) Presence of neutrophil-bearing antigen in lymphoid organs of immune mice. Blood 108, 3094-3102.
59. Deng, G. M., Nilsson, I. M., Verdrengh, M., Collins, L. V., Tarkowski, A. (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5, 702-705.
60. Wilkinson, N. Z., Kingsley, G. H., Sieper, J., Braun, J., Ward, M. E. (1998) Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response. Arthritis Rheum. 41, 845-854.
61. Van der Heijden, I., Wilbrink, B., Schouls, L. M., van Embden, J. D., Breedveld, F. C., Tak, P. P. (1999) Detection of mycobacteria in joint samples from patients with arthritis using a genus-specific polymerase chain reaction and sequence analysis. Rheumatology (Oxford) 38, 547-553.
62. Van der Heijden, I. M., Wilbrink, B., Tchetverikov, I., Schrijver, I. A., Schouls, L. M., Hazenberg, M. P., Breedveld, F. C., Tak, P. P. (2000) Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum. 43, 593-598.
63. Lemmel, E. M., Brackertz, D., Franke, M., Gaus, W., Hartl, P. W., Machalke, K., Mielke, H., Obert, H. J., Peter, H. H., Sieper, J. (1988) Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-γ. Rheumatol. Int. 8, 87-93.
64. Cannon, G. W., Emkey, R. D., Denes, A., Cohen, S. A., Saway, P. A., Wolfe, F., Jaffer, A. M., Weaver, A. L., Manaster, B. J., McCarthy, K. A. (1993) Prospective 5-year followup of recombinant interferon-γ in rheumatoid arthritis. J. Rheumatol. 20, 1867-1873.
65. German Lymphokine Study Group (1992) Double blind controlled phase III multicenter clinical trial with interferon γ in rheumatoid arthritis. Rheumatol. Int. 12, 175-185.
66. Machold, K. P., Neumann, K., Smolen, J. S. (1992) Recombinant human interferon γ in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann. Rheum. Dis. 51, 1039-1043.